NorthWest Biotherapeutics Inc (NWBO)

[sentiment_stocks]

The crossover data was obtained from shipping records. Problem is, those records would be a near perfect unblind of the trial.

True, NWBO was never unblinded. Just the shipping records under control of LP were used to generate unblinded summaries to LL et al.

What you suggest is not what happened… what you are stating occurred is simply your THESIS. However there is a problem with your thesis and that is that almost always it is the CRO which handles the drug or vaccine dispersement, not the manufacturer or the sponsor. So Cognate very likely simply shipped the vaccines to the CRO (Parexel and Synteract) who then distributed the vaccines to their respective treatment centers.

And because both the DCVax-L vaccine and the placebo vaccine were manufactured for all the patients, then Cognate would have shipped both sets (treatment and placebo) to the CRO, who would be responsible for distributing the vials to the treatment centers. So your theory that LP had access to the shipping records via Cognate, and therefore knew which patient began as treatment and which patient began as control does not hold water because (1) Cognate very likely shipped both sets of vials to the CRO, and (2) LP wouldn’t have access to the CROs blinded shipping records.